J&J must pay $8 billion in case over male breast growth linked to Risperdal

J&J must pay $8 billion in case over male breast growth linked to Risperdal

A Philadelphia jury awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug they made. The plaintiff’s attorneys said the drug led to abnormal growth of female breast tissue in boys. Johnson and Johnson immediately denounced the award, vowing immediate action to overturn it.

Chris
Chris
porcus
porcus 3 months

$8 Billion-with-a-B is ridiculous and excessive to one dude for a pair of tits, by a few zeros.

Top in Business
Get the App